bplist00Ñ_WebMainResourceÕ
^WebResourceURL_WebResourceData_WebResourceMIMEType_WebResourceTextEncodingName_WebResourceFrameName_?file:///Users/christianbopoulsen/Downloads/atc-kode.xls-38.htmlOMÂ
Sundhedsdatastyrelsen - Statistikker
- ATC code: C08DA01, C08DA51, C08DB01
- Search variable: Volume sold
- Age groups: 0 - 4 y.o., 5 - 9 y.o., 10 - 14 y.o., 15 - 19 y.o.
- Gender: Gender, combined
- Sector: Primary sector
- Region: Entire Denmark
- ATC code: C08DA01 (verapamil)
|
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
Share of prescription sales to individuals of total primary sales |
>99% |
99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
Prescription sales to individuals |
Volume sold (1,000 DDD) |
0 - 4 y.o. |
0 |
- |
0 |
0 |
0 |
- |
- |
- |
- |
0 |
- |
- |
0 |
0 |
- |
0 |
0 |
- |
5 - 9 y.o. |
0 |
0 |
0 |
0 |
0 |
0 |
- |
0 |
- |
- |
0 |
- |
- |
0 |
0 |
0 |
0 |
- |
10 - 14 y.o. |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
0 |
15 - 19 y.o. |
3 |
3 |
2 |
1 |
2 |
3 |
1 |
2 |
3 |
4 |
4 |
4 |
5 |
3 |
5 |
5 |
4 |
3 |
- ATC code: C08DA51 (verapamil, combinations)
|
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
Share of prescription sales to individuals of total primary sales |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Prescription sales to individuals |
Volume sold (1,000 DDD2) |
0 - 4 y.o. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
5 - 9 y.o. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
10 - 14 y.o. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
15 - 19 y.o. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- ATC code: C08DB01 (diltiazem)
|
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
Share of prescription sales to individuals of total primary sales |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
>99% |
- |
>99% |
>99% |
>99% |
>99% |
Prescription sales to individuals |
Volume sold (1,000 DDD) |
0 - 4 y.o. |
0 |
0 |
0 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
5 - 9 y.o. |
- |
- |
0 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
10 - 14 y.o. |
- |
- |
- |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
- |
- |
- |
1 |
0 |
0 |
15 - 19 y.o. |
0 |
0 |
0 |
0 |
- |
- |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
- |
0 |
0 |
1 |
0 |
- Legend
- 0 or 0.0 The value is so small that it can not be displayed after rounding.
- - No sale, no data or not calculated.
- Notes
- 2 : Some medicines are Combination Products. This has implications for the DDD value.
Ytext/htmlUUTF-8P ( 7 I _ } ” ÖNœN¦N¬
N